NALOXONE IN ACUTE CORONARY SYNDROMES AND CARDIOGENIC SHOCK PATIENTS PRETREATED WITH MORPHINE. A CLINICAL AND ECHOCARDIOGRAPHIC STUDY

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 4

Abstract

Purpose: The use of morphine is common in acute heart failure critically ill patients and although it remains indicated in guidelines however now beginning to be controversial. Naloxone could improve hemodynamic status in cardiogenic shock (CS) patients pretreated with morphine. Objetive: The objectives were to evaluate whether naloxone administration to patients treated with morphine improves haemodynamic and echocardiographic parameters. Methods: Intensive Care Unit of Jaén University Hospital. It is an observational prospective study. Only exists an unique cohort treated with naloxone; there is no control group or randomization. Inclusion criteria were 1) acute myocardial infarction with CS and considered "no alternative receiving invasive mechanical ventilation", 2) previous administration of ≥ 10 mg of morphine chloride. Naloxone was used as “compassionate use”. The study period was from January 2012 to September 2013. Hemodynamic and echocardiographic variables including speckle tracking techniques were evaluated before and after naloxone administration. Statistical analysis was performed using the Student t test. Results: 37 patients were included. They had a mean age 73.08 ± 3.41 years, 54% being male. Clinical parameters improved after naloxone administration, especially systolic blood pressure [82.33 ± 2.27 to 117.35 ± 1.89] mmHg. The respiratory and heart frequencies decreased and GCS were normalized. LVEF [261 ± 01 - 338 ± 01]; left ventricle strain [-9.503-(-11.91)], and left ventricle SR [-.48-(-1.12)] increased after naloxone. An increase in right ventricular contractility was also observed. Conclussion: This study generates the hypothesis that naloxone could improve clinical and echocardiographic parameters in CS patients treated with morphine. The morphine use should be approached with caution.

Authors and Affiliations

Ruiz-Bailén, Manuel

Keywords

Related Articles

HEPATOPROTECTIVE AND ANTIDIABETIC EFFECTS OF NIGELLA SATIVA SEED EXTRACT IN ALLOXAN-INDUCED DIABETIC MICE: AN EXPERIMENTAL STUDY WITH HISTOPATHOLOGICAL INVESTIGATIONS

Objectives Diabetes Mellitus (DM) is known to induce oxidative stress causes liver tissue injury and changes the homeostasis of carbohydrate, lipid and protein metabolism. Hence, present study is aimed to investigate the...

ASSESSMENT OF EMOTIONAL AND BEHAVIOURAL PROBLEMS AMONG CHILDREN OF EMPLOYED MOTHERS RESIDING IN A SELECTED COMMUNITY AREAS

Background: Some mothers may choose to stay at home and adopt the traditional homemaker role. Others might prefer to work outside home, living life to its full potential. When choosing between staying at home and working...

AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE EFFICACY OF SEKA AND NASYA IN THE MANAGEMENT OF SHUSHKAKSHIPAKA W.S.R TO DRY EYES IN MENOPAUSAL WOMEN

Dry eye is a multifactorial ocular surface disease that causes ocular pain, discomfort and decreased visual acuity. It is more prevalent in the females and specifically in the menopausal and postmenopausal age group. Thi...

ARUM CYRENIACUM: INVESTIGATION OF VOLATILES AND HEAVY METALS REMOVING CAPACITY

Arum cyreniacum is an endemic Libyan plant growing in Aljabal Al-Akhder region.Though Arum species have been used since antiquity in herbal medicine for a wide array of human disorders, information on the medicinally imp...

A LUMP IN A MILLION- TUBULAR ADENOMA OF BREAST

Tubular adenomas are rare epithelial tumors of the breast. They are sometimes called “pure adenomas” because they tend not to show excessive epithelial hyperplasia and connective tissue growth. Only a few cases have been...

Download PDF file
  • EP ID EP649053
  • DOI -
  • Views 167
  • Downloads 0

How To Cite

Ruiz-Bailén, Manuel (2017). NALOXONE IN ACUTE CORONARY SYNDROMES AND CARDIOGENIC SHOCK PATIENTS PRETREATED WITH MORPHINE. A CLINICAL AND ECHOCARDIOGRAPHIC STUDY. World Journal of Pharmaceutical and life sciences, 3(4), 6-12. https://europub.co.uk./articles/-A-649053